Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Pacific Biosciences of California Inc |
9/12 | 2,430 USD
+4,74% |
+4,74% |
|
Pacira BioSciences Inc |
8/12 | 24,420 USD
+1,79% |
+1,79% |
|
PainReform Ltd |
8/12 | 0,953 USD
-0,77% |
-0,77% |
|
Passage Bio Inc |
8/12 | 9,920 USD
+7,71% |
+7,71% |
|
PAVmed Inc |
9/12 | 0,368 USD
+6,17% |
+6,17% |
|
PDS Biotechnology Corporation |
8/12 | 0,898 USD
+3,25% |
+3,25% |
|
Penumbra Inc |
8/12 | 294,830 USD
-1,94% |
-1,94% |
Perimeter Medical Imaging AI Inc |
8/12 | 0,180 CAD
0,00% |
0,00% |
|
Perrigo Company plc |
9/12 | 13,320 USD
+1,83% |
+1,83% |
|
Personalis Inc |
8/12 | 9,820 USD
+2,72% |
+2,72% |
|
Perspective Therapeutics Inc |
9/12 | 2,520 USD
+5,00% |
+5,00% |
|
PetVivo Holdings Inc |
8/12 | 1,070 USD
-2,28% |
-2,28% |
|
Pfizer |
9/12 | 25,330 USD
-1,71% |
-1,71% |
Pharming Group N.V. |
9/12 | 1,459 EUR
+0,21% |
+0,21% |
|
Pharming Group N.V. |
9/12 | 17,010 USD
+0,12% |
+0,12% |
|
Phathom Pharmaceuticals Inc |
8/12 | 14,900 USD
+2,19% |
+2,19% |
|
Phibro Animal Health Corp. |
8/12 | 40,080 USD
+2,35% |
+2,35% |
|
Philips |
9/12 | 23,240 EUR
-0,26% |
-0,26% |
|
Phio Pharmaceuticals Corp |
9/12 | 1,150 USD
+1,77% |
+1,77% |
Plant Advanced Technologies Pat |
8/12 | 8,800 EUR
+0,23% |
+0,23% |
|
Pliant Therapeutics Inc |
8/12 | 1,280 USD
+5,79% |
+5,79% |
|
Plus Therapeutics Inc |
8/12 | 0,630 USD
-3,08% |
-3,08% |
Polarean Imaging Plc |
8/12 | 0,215 GBX
+26,47% |
+26,47% |
|
Polypid Ltd |
8/12 | 3,980 USD
+0,25% |
+0,25% |
|
Poxel |
9/12 | 0,228 EUR
-3,80% |
-3,80% |
|
Praxis Precision Medicines Inc |
8/12 | 270,980 USD
+9,27% |
+9,27% |
|
Precigen Inc |
9/12 | 3,510 USD
-4,88% |
-4,88% |
|
Precipio Inc |
9/12 | 24,450 USD
-1,65% |
-1,65% |
|
Precision Biosciences Inc |
8/12 | 4,760 USD
-5,18% |
-5,18% |
|
Predictive Oncology Inc |
9/12 | 5,560 USD
+13,47% |
+13,47% |
|
Prelude Therapeutics Inc |
8/12 | 1,460 USD
0,00% |
0,00% |
|
Prestige Consumer Healthcare Inc |
8/12 | 60,310 USD
-0,84% |
-0,84% |
|
Profound Medical Corp |
8/12 | 6,780 USD
+2,73% |
+2,73% |
|
ProMIS Neurosciences Inc. |
8/12 | 7,620 USD
-3,61% |
-3,61% |
|
ProPhase Labs Inc |
8/12 | 0,138 USD
+6,15% |
+6,15% |
|
ProQR Therapeutics N.V |
9/12 | 2,320 USD
+9,43% |
+9,43% |
|
Protagonist Therapeutics Inc |
8/12 | 90,250 USD
+0,67% |
+0,67% |
|
Protara Therapeutics Inc |
8/12 | 5,720 USD
+2,51% |
+2,51% |
|
Proteome Sciences plc |
9/12 | 2,400 GBX
+1,69% |
+1,69% |
|
Prothena Corporation plc |
9/12 | 10,320 USD
-3,82% |
-3,82% |
|
PTC Therapeutics Inc |
8/12 | 76,910 USD
-0,45% |
-0,45% |
|
Pulmatrix Inc |
9/12 | 4,370 USD
+8,98% |
+8,98% |
|
Pulmonx Corp |
8/12 | 2,040 USD
+1,49% |
+1,49% |
|
Pulse Biosciences Inc |
8/12 | 13,490 USD
+1,66% |
+1,66% |
|
Puma Biotechnology Inc |
9/12 | 5,520 USD
+2,22% |
+2,22% |
|
PureTech Health Plc |
8/12 | 16,750 USD
-7,20% |
-7,20% |
|
PureTech Health Plc |
8/12 | 123,800 GBX
+1,48% |
+1,48% |